Howmet Aerospace (NYSE:HWM) Azioni

HOWMET AEROSPACE INC

Howmet Aerospace

Howmet Aerospace Inc produces products that are majorly used in aerospace, commercial transportation, and industrial and other markets. The company seeks to provide its customers with solutions by offering differentiated products such as airfoils with cooling and coatings for extreme temperature applications, specially designed fasteners for lightweight composite airframe construction, reduced assembly costs, lightning strike protection, and lightweight aluminum commercial wheels. It has four reportable segments namely, Engine Products, Fastening Systems, Engineered Structures, and Forged Wheels.

Shibuya,,Tokyo,,Japan,-,March,5,2022:,Exterior,Of,The

Long Ideas

Tech

Trading Ideas

PLTR

UBER

VRSN

Le azioni dell&#39;S&amp;P 500 che stanno registrando le migliori performance dell&#39;anno. Quali sono le società in forte crescita?

I migliori performer dell&#39;S&amp;P 500: ecco le azioni che stanno volando alto

Howmet Aerospace Inc

HOWA MACHINERY LTD by HOWA MACHINERY LTD.

Howmet Aerospace Inc. $3.75 Preferred Stock

Raymond James analyst Frederic Bastien downgrades Brookfield Renewable (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEP#NYSE">BEP</a>) from Strong Buy to Outperform and maintains the price target from $44 to $44.

News

Downgrades

Price Target

Analyst Ratings

Raymond James Downgrades Brookfield Renewable to Outperform, Maintains Price Target to $44

General

NVDA

Reuters Reports Top Republican On House China Committee Objects To Resumption Of Nvidia H20 Chip Shipments To China In Letter To Lutnick

DA Davidson analyst Jeffrey Rulis maintains Banner (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BANR#NASDAQ">BANR</a>) with a Neutral and raises the price target from $67 to $72.

BANR

DA Davidson Maintains Neutral on Banner, Raises Price Target to $72

WIIM

Humana shares are trading lower after the company reportedly lost its Medicare bonus payment lawsuit.

Raymond James analyst David Long maintains Citizens Financial Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CFG#NYSE">CFG</a>) with a Strong Buy and raises the price target from $48 to $57.

Raymond James Maintains Strong Buy on Citizens Financial Group, Raises Price Target to $57

BCLI

BrainStorm Cell Therapeutics is trading lower after receiving a delisting notice from Nasdaq effective July 18, 2025.

Raymond James analyst Jayson Bedford maintains Abbott Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>) with a Outperform and lowers the price target from $142 to $141.

Raymond James Maintains Outperform on Abbott Laboratories, Lowers Price Target to $141

DA Davidson analyst Kurt Yinger maintains Boise Cascade (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BCC#NYSE">BCC</a>) with a Buy and lowers the price target from $115 to $100.

DA Davidson Maintains Buy on Boise Cascade, Lowers Price Target to $100

B of A Securities analyst Tazeen Ahmad maintains Sarepta Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>) with a Neutral and lowers the price target from $28 to $20.

SRPT

B of A Securities Maintains Neutral on Sarepta Therapeutics, Lowers Price Target to $20

Susquehanna analyst Christopher Stathoulopoulos maintains United Airlines Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>) with a Positive and raises the price target from $81 to $109.

Susquehanna Maintains Positive on United Airlines Holdings, Raises Price Target to $109

<a href="https://www.bloomberg.com/news/articles/2025-07-18/humana-loses-bid-to-reverse-medicare-bonus-payment-cut?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-07-18/humana-loses-bid-to-reverse-medicare-bonus-payment-cut?embedded-checkout=true</a>

'Humana Loses Bid to Reverse Medicare Bonus Payment Cut'- Bloomberg

Susquehanna analyst James Friedman maintains Infosys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INFY#NYSE">INFY</a>) with a Neutral and raises the price target from $17 to $18.

INFY

Susquehanna Maintains Neutral on Infosys, Raises Price Target to $18

Susquehanna analyst James Friedman maintains Etoro Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETOR#NASDAQ">ETOR</a>) with a Neutral and lowers the price target from $70 to $66.

ETOR

Susquehanna Maintains Neutral on Etoro Group, Lowers Price Target to $66

Stifel analyst Steven Wieczynski maintains Six Flags Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUN#NYSE">FUN</a>) with a Buy and lowers the price target from $50 to $43.

Stifel Maintains Buy on Six Flags Entertainment, Lowers Price Target to $43

Robinhood (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) CEO <a href="https://www.benzinga.com/25/04/44825414/robinhood-ceo-brushes-off-concerns-prediction-markets-are-gambling-they-have-societal-value-across-all-categories">Vlad Tenev</a> is stepping beyond trading apps with a new venture: Harmonic AI, a startup aiming to create what it calls "mathematical superintelligence." The company<a href="https://www.businesswire.com/news/home/20250710118878/en/Harmonic-Raises-%24100-Million-Series-B-to-Accelerate-Development-of-Mathematical-Superintelligence"> last month announced</a> the closing of a $100 million Series B funding round, bringing its valuation to $875 million.&nbsp;
Tenev co-founded Palo Alto-based Harmonic in 2023 alongside CEO Tudor Achim, a former executive at autonomous driving company Helm.ai. Though he is not running the company day to day, Tenev serves as executive chairman,<a href="https://www.bloomberg.com/news/articles/2025-07-10/robinhood-ceo-s-ai-math-startup-valued-at-nearly-900-million"> Bloomberg</a> reports.
Don't Miss:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/mode-mobile-accredited-investor-offer">Accredited investors can claim pre-IPO shares of Mode Mobile for just $0.30</a>—with up to 120% bonus shares—before this Uber-style disruption hits the public markets</li>
<li>$100k+ in investable assets? <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Match with a fiduciary advisor for free to learn how you can maximize your retirement and save on taxes</a> – no cost, no obligation.</li>
</ul>
Harmonic AI says the round was led by Kleiner Perkins with major backing from Paradigm, and included Ribbit Capital along with existing investors <a href="https://www.benzinga.com/news/25/05/45336180/former-openai-cto-mira-muratis-2b-ai-startup-thinking-machines-lab-sets-50m-investment-minimum-backed-by-andreessen-horowitz-and-sequoia-capital">Sequoia Capital</a>, Index Ventures, and Charlie Cheever.
The startup<a href="https://harmonic.fun/news"> closed</a> a $75 million Series A round last year led by Sequoia Capital, with significant participation from Index Ventures and additional backing from GreatPoint Ventures, Era Funds, Blossom Capital, DST Global partners, Elefund, Nikesh Arora, and Jared Leto.
<h2 class="wp-block-heading">A Math-First AI That Promises No Hallucinations and Full Verification</h2>
Tenev said the company's near-term goal is to build AI that solves complex math problems better than any human. The long-term vision includes solving unsolved mathematical problems and expanding the approach to fields like physics and computer science, Bloomberg reports.
Trending: Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — <a href="https://www.benzinga.com/money/americans-spend-1000-per-year-on-plastic-water-bottles-kara-pod-gives-you-clean-drinking-water-by-pulling-moisture-from-the-air">And You Can Invest At Just $6.37/Share</a>
Unlike OpenAI or Google's large language models, Harmonic emphasizes formal logic and mathematical reasoning over natural language training, which the company says helps eliminate the risk of hallucinations often seen in chatbots.
"We can ensure that every piece of output and every step in our model's reasoning is verifiably correct," Tenev told Bloomberg. "That is just a very different approach to building AI models that I think is going to be the approach that dominates in the future."
According to <a href="https://harmonic.fun/news">Harmonic</a>, Aristotle has already shown measurable improvement. In tests using the MiniF2F benchmark, the model's score increased from 83% to 90% in a single month.
"Aristotle's MSI is uniquely suited for mission-critical applications where there is no margin for error, such as generating verified software and by formally verifying existing code – a breakthrough for industries including blockchain, financial services, aerospace and other safety-sensitive systems," Achim said in a statement.
See Also: This AI-Powered Trading Platform Has 5,000+ Users, 27 Pending Patents, and a $43.97M Valuation — <a href="https://www.benzinga.com/money/finally-a-fully-automated-trading-platform-for-individual-investors?">You Can Become an Investor for Just $500.25</a>
<h2 class="wp-block-heading">‘You Never Want to Take the Highest Offer': Why Tenev Chose a Sub-Unicorn Valuation</h2>
Despite having the investor interest to cross the $1 billion valuation mark, Tenev said he intentionally stopped at $875 million. "You never want to take the highest offer," he told Bloomberg, adding that optimizing for valuation is not the right move for a startup with long-term scientific ambitions.
According to <a href="https://www.inc.com/chris-morris/elon-musk-y-combinators-ai-startup-school/91204518">Inc.</a>, Elon Musk recently told Y Combinator's AI Startup School that digital superintelligence could arrive this year or next. Tenev, who pursued a Ph.D. in math at UCLA before co-founding Robinhood, is now pushing toward advanced AI in a similar timeframe.
As the company scales its team and expands access to its flagship AI system, Aristotle, Harmonic is continuing to recruit engineers, researchers, and builders who want to push the boundaries of verified reasoning, according to its<a href="https://harmonic.fun/about"> website</a>.
Read Next: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"> Here&#8217;s how you can earn passive income with just $10.</a>
Image: Shutterstock

HOOD

'You Never Want To Take The Highest Offer': Robinhood CEO's AI Startup Raises $100M, Hits $875M Valuation With Backing From Kleiner Perkins

Stifel analyst Tore Svanberg maintains Texas Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) with a Hold and raises the price target from $160 to $192.

Stifel Maintains Hold on Texas Instruments, Raises Price Target to $192

US Foods Hldg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USFD#NYSE">USFD</a>) has outperformed the market over the past 5 years by 17.27% on an annualized basis producing an average annual return of 31.39%. Currently, US Foods Hldg has a market capitalization of $19.43 billion. 
Buying $1000 In USFD: If an investor had bought $1000 of USFD stock 5 years ago, it would be worth $3,991.87 today based on a price of $84.00 for USFD at the time of writing.
<h3>US Foods Hldg's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752848118_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

USFD

Here's How Much $1000 Invested In US Foods Hldg 5 Years Ago Would Be Worth Today

Canaccord Genuity analyst Whitney Ijem maintains Rhythm Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYTM#NASDAQ">RYTM</a>) with a Buy and raises the price target from $92 to $105.

RYTM

Canaccord Genuity Maintains Buy on Rhythm Pharmaceuticals, Raises Price Target to $105

Stifel analyst Tore Svanberg maintains Semtech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTC#NASDAQ">SMTC</a>) with a Buy and raises the price target from $45 to $54.

SMTC

Stifel Maintains Buy on Semtech, Raises Price Target to $54

Stifel analyst Tore Svanberg maintains Silicon Laboratories (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLAB#NASDAQ">SLAB</a>) with a Buy and raises the price target from $144 to $160.

Comments

Howmet Aerospace

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO